STAS阳性IA1-2期非小细胞肺癌的切除范围
OBJECTIVES: Sublobar resection has demonstrated noninferiority to lobectomy in unselected stage IA non-small cell lung cancer (NSCLC), but the optimal surgical approach in tumors with spread-through air spaces (STAS) remains unclear.…
要点
- STAS阳性IA1-2期NSCLC亚肺叶切除的累积复发风险显著高于肺叶切除(SHR 7.60)。
- STAS阳性者亚肺叶切除的肺癌特异性死亡风险更高(SHR 5.12)。
- 楔形切除的无复发生存劣于肺叶切除,肺段切除未显示劣效。
核心结论
- STAS阳性IA1-2期NSCLC中,亚肺叶切除尤其楔形切除与更差的无复发生存相关。
研究设计与样本
- 回顾性队列研究,纳入2018年2月至2022年1月单中心445例病理IA1-2期NSCLC肺切除患者,其中STAS阳性158例(35.5%)。
临床怎么用
- 对STAS阳性IA1-2期NSCLC,应优先考虑肺叶切除以降低复发风险。
- 选择亚肺叶切除时,楔形切除可能需谨慎,肺段切除或可考虑但需进一步验证。
局限性
- 单中心回顾性研究,样本量有限,倾向评分匹配后仅40对。
- 探索性分析中楔形和肺段切除的样本量可能较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sublobar resection has demonstrated noninferiority to lobectomy in unselected stage IA non-small cell lung cancer (NSCLC), but the optimal surgical approach in tumors with spread-through air spaces (STAS) remains unclear. This study examines how extent of resection influences clinical outcomes in patients with STAS-positive stage IA1-2 NSCLC. METHODS: Patients who underwent lung resection for primary pathologic stage IA1-2 NSCLC between February 2018 and January 2022 at a tertiary academic institution were included. In the STAS-positive cohort, multivariable competing risk models were used to assess cumulative incidence of recurrence and lung cancer-related death after lobectomy versus sublobar resection, and propensity score-matched analysis was performed for overall survival and recurrence-free survival. Exploratory analysis was performed to evaluate outcomes after specific resection type (lobectomy, segmentectomy, wedge) in the STAS-positive cohort. RESULTS: A total of 445 patients met inclusion criteria, of whom 158 (35.5%) were STAS-positive. Within the STAS-positive cohort, recurrence was significantly more frequent after sublobar resection (subdistribution hazard ratio, 7.60; 95% confidence interval, 1.85-31.33, P = .005), and lung cancer-specific mortality was higher (subdistribution hazard ratio, 5.12; 95% confidence interval, 1.03-25.62; P = .047). Propensity-score matching yielded 40 well-balanced pairs. Overall survival was similar between lobectomy and sublobar resection (5-year overall survival: lobectomy 91.5% vs sublobar 80.3%, P = .18). In contrast, recurrence-free survival was significantly worse after sublobar resection (5-year recurrence-free survival: lobectomy 88.8% vs sublobar 66.1%, P = .042). On exploratory analysis, inferior recurrence-free survival was observed for wedge resection (P = .024) but not for segmentectomy (P = .324) when compared with lobectomy. CONCLUSIONS: Sublobar resection, particularly wedge resection, is associated with worse recurrence-free survival for STAS-positive stage IA1-2 NSCLC.
引用
- Yang Z, Mino-Kenudson M, Lanuti M, et al. Extent of resection for spread-through air spaces-positive stage IA1-2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2025. PMID: 41443465. doi:10.1016/j.jtcvs.2025.12.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。